| shareholder_name | Pandanus Associates Inc. |
|---|---|
| stock_code | 02487 |
| canonicalcorporation | Cutia Therapeutics |
| url | https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20240531E00023&sa2=ns&sid=437415&sd=31/05/2023&ed=31/05/2024&sa1=cl&scsd=31/05/2023&sced=31/05/2024&sc=02487&src=Main&lang=EN&tk=ds |
| formserialnumber | CS20240531E00023 |
| form3 | 20240531E00023 |
| event_type | CS |
| formtype | FORM 2 - Corporate Substantial Shareholder Notice |
| assetclass | Ordinary Shares |
| number_issued | 304738625 |
| registeredoffice | 11 Keewaydin Drive, Suite 100, Salem, NH, USA 03079 |
| principalplace | N/A |
| dateevent | 2024-05-28 |
| dateformfiled | 2024-05-31 |
| position1_eventcode | 1201 |
| position1_codebefore | 2201 |
| position1_numberofshares | 1,529,200 |
| position1_currency | HKD |
| position1_highestprice | 10.1800 |
| position1_averageprice | 9.1321 |
| long_number_before | 18969585 |
| long_number_after | 17440385 |
| long_number_change | -1529200 |
| long_percent_before | 6.22 |
| long_percent_after | 5.72 |
| long_percent_change | -0.5 |
| net_number_before | 18969585 |
| net_percent_before | 6.22 |
| net_number_after | 17440385 |
| net_percent_after | 5.72 |
| net_percent_change | -0.5 |
| long_percent_before_actual | 6.22487057556291 |
| long_percent_after_actual | 5.723063494166517 |
| net_percent_before_actual | 6.22487057556291 |
| net_percent_after_actual | 5.723063494166517 |
| net_percent_change_actual | -0.5018070813963931 |